Dry Eye (Keratoconjunctivitis Sicca) in Dogs – Symptoms, Diagnosis & Treatment
Disclaimer: This article is for informational purposes only and does not substitute for professional veterinary advice. If you suspect your dog has dry eye or any other health condition, consult a licensed veterinarian for proper diagnosis and treatment.
What Is Dry Eye (Keratoconjunctivitis Sicca)?
Dry eye in dogs, known medically as keratoconjunctivitis sicca (KCS), is a chronic condition in which the tear glands produce insufficient tears to keep the eye properly lubricated and nourished. Without adequate tear film, the cornea and surrounding conjunctival tissues become inflamed, irritated, and vulnerable to infection and permanent damage. KCS is one of the most common eye diseases diagnosed in dogs and, if left untreated, can lead to severe pain, corneal ulceration, and even blindness.
The tear film serves critical functions beyond simple moisture. It delivers oxygen and nutrients to the avascular cornea, flushes away debris and pathogens, and provides a smooth optical surface for clear vision. Tears are produced primarily by two glands: the lacrimal gland (located above the eye) and the gland of the third eyelid (nictitating membrane). In KCS, one or both of these glands become damaged or dysfunctional, drastically reducing the aqueous (watery) component of the tear film. The remaining tears become thick and mucoid, creating the characteristic sticky discharge that many owners first notice.
The condition is almost always progressive without treatment. As the corneal surface dries, the body compensates by growing blood vessels and depositing pigment across the cornea — a process called corneal neovascularization and pigmentary keratitis. Over time, these changes can obscure the dog's vision entirely.
Symptoms of Dry Eye (Keratoconjunctivitis Sicca) in Dogs
Early Signs
- Thick, stringy, or mucoid eye discharge — often yellow-green, recurring despite cleaning
- Redness of the conjunctiva (the pink tissue surrounding the eye)
- Frequent blinking or squinting (blepharospasm)
- Dull, lackluster appearance to the corneal surface
- Mild pawing or rubbing at the eyes
- Recurrent eye infections that seem to clear with antibiotics but quickly return
Progressive Symptoms
- Heavy, persistent mucoid to mucopurulent discharge that accumulates rapidly after cleaning
- Corneal pigmentation — a brownish-black discoloration spreading across the clear part of the eye
- Corneal vascularization — visible blood vessels growing across the normally clear cornea
- Corneal scarring or opacity — the eye takes on a cloudy, hazy appearance
- Noticeable decrease in vision — bumping into objects, reluctance to navigate in dim light
- Dry, crusty appearance of the eyelids and surrounding skin
- Keratinization of the corneal surface — the normally smooth cornea becomes rough and irregular
Emergency Signs
- Sudden intense pain — holding the eye shut, crying, or refusing to be touched near the face
- Corneal ulceration — a visible defect or divot on the corneal surface, often with intense squinting
- Eye rupture or descemetocele — a bulging or collapsed appearance to the eye (a life-threatening emergency)
- Sudden blindness or dramatic worsening of vision
- Significant swelling around the eye with purulent (pus-like) discharge
What Causes Dry Eye (Keratoconjunctivitis Sicca) in Dogs?
The most common cause of KCS in dogs is immune-mediated destruction of the tear glands. In approximately 75–80% of cases, the dog's own immune system mistakenly attacks and destroys the lacrimal and third-eyelid glands, progressively reducing tear production. The exact trigger for this autoimmune response is not fully understood, but genetics play a significant role.
Other recognized causes and risk factors include:
- Drug-induced KCS — Certain medications, most notably sulfonamide antibiotics (such as sulfasalazine used for colitis), atropine, and some anesthetic agents, can cause temporary or permanent tear gland damage. Etodolac, a non-steroidal anti-inflammatory drug, has also been implicated.
- Surgical removal of the third eyelid gland — Historically, prolapsed third-eyelid glands ("cherry eye") were treated by excision rather than surgical repositioning. Removing this gland eliminates a significant source of tear production and is a well-documented cause of KCS later in life.
- Congenital conditions — Some dogs are born with underdeveloped or absent tear glands (lacrimal gland agenesis or hypoplasia).
- Neurogenic KCS — Damage to the nerves supplying the tear glands (particularly the facial nerve or parasympathetic fibers) can reduce tear secretion. This form often affects only one eye and may accompany a dry nostril on the same side.
- Infectious disease — Canine distemper virus can damage the lacrimal glands, sometimes permanently.
- Endocrine disorders — Hypothyroidism, diabetes mellitus, and Cushing's disease (hyperadrenocorticism) have been associated with decreased tear production.
- Radiation therapy — Radiation to the head or orbital region can damage tear glands as a side effect.
- Chronic blepharoconjunctivitis — Long-standing inflammation of the eyelids and conjunctiva can secondarily affect tear gland function.
- Age — While KCS can occur at any age, it is most commonly diagnosed in middle-aged to older dogs (4–10 years), though breed-predisposed dogs may develop signs earlier.
Breeds Most at Risk
KCS has a strong breed predisposition, reflecting the immune-mediated genetic basis of the disease. Brachycephalic (short-nosed) breeds are disproportionately affected, in part because their prominent eyes and wider palpebral fissures (eye openings) increase tear evaporation, and in part because of breed-specific immune tendencies.
Breeds with the highest documented risk include:
- English Cocker Spaniel — among the most frequently affected breeds worldwide
- American Cocker Spaniel
- Cavalier King Charles Spaniel
- English Bulldog
- Lhasa Apso
- Shih Tzu
- West Highland White Terrier
- Pug
- Miniature Schnauzer
- Yorkshire Terrier
- Boston Terrier
- Pekingese
- Bloodhound
- English Springer Spaniel
How Dry Eye (Keratoconjunctivitis Sicca) Is Diagnosed
Initial Examination
A veterinarian will begin with a thorough ophthalmic examination, evaluating the eyelids, conjunctiva, cornea, and anterior chamber of the eye. The pattern of discharge, corneal clarity, and degree of surface changes provide initial clinical clues.
Schirmer Tear Test (STT)
The Schirmer tear test is the definitive diagnostic test for KCS and is simple, inexpensive, and performed in-office. A small, standardized strip of absorbent paper is placed inside the lower eyelid for exactly 60 seconds. The length of the moistened paper is measured in millimeters:
- Normal: 15–25 mm/min
- Early or subclinical KCS: 10–14 mm/min
- Definite KCS: Less than 10 mm/min
- Severe KCS: Less than 5 mm/min
Fluorescein Stain Test
A fluorescein dye is applied to the corneal surface to check for corneal ulcers or epithelial defects. In dry eyes, the dye may reveal punctate (tiny dot-like) staining patterns across the cornea, indicating areas of surface cell damage even before a frank ulcer develops. This test is typically included in the standard eye exam at no additional charge.
Rose Bengal Staining
In some cases, rose bengal dye is used to highlight devitalized (dead or dying) corneal and conjunctival cells, providing a more sensitive assessment of surface damage from dryness.
Tear Film Break-Up Time (TBUT)
This test measures how quickly the tear film begins to break apart on the corneal surface after a blink. A shortened TBUT supports a diagnosis of qualitative tear film deficiency, even when the Schirmer test values are borderline.
Additional Diagnostics
- Culture and sensitivity — if infection is present or suspected, to guide antibiotic selection (~$75–$150)
- Cytology — microscopic examination of cells from the conjunctiva to evaluate for inflammatory patterns
- Referral to a veterinary ophthalmologist — for complex cases, advanced imaging (such as ocular ultrasound), or surgical planning (~$150–$300 for a specialist consultation)
- Blood work — thyroid panel, blood glucose, and other tests if an underlying systemic disease is suspected (~$150–$350)
Treatment Options for Dry Eye (Keratoconjunctivitis Sicca)
Medical Management
Medical therapy is the cornerstone of KCS management, and most dogs require lifelong treatment. The goals are to stimulate natural tear production, replace missing tears, reduce inflammation, and prevent infection.
Tear stimulants (immunomodulatory agents):- Cyclosporine A (Optimmune) — The primary treatment for immune-mediated KCS. This topical ophthalmic ointment or solution suppresses the local immune attack on the tear glands and simultaneously stimulates tear production. Applied once or twice daily. Approximately 70–80% of dogs show significant improvement. Cost: ~$30–$70/month.
- Tacrolimus (topical) — A more potent immunomodulatory agent used when cyclosporine alone is insufficient. Compounded as a 0.02–0.03% ophthalmic solution or ointment. Often effective in dogs who fail to respond to cyclosporine. Cost: ~$40–$90/month (compounded).
- Applied multiple times daily (every 2–6 hours) to supplement natural tear production
- Gel-based formulations (such as those containing carbomer or hyaluronic acid) last longer on the eye than watery drops
- Used alongside tear stimulants, not as a sole treatment. Cost: ~$10–$25/bottle.
- Used when secondary bacterial infection is present
- Often combined with anti-inflammatory medications
- Common choices include tobramycin, neomycin-polymyxin-bacitracin, or chloramphenicol
- Topical corticosteroids (such as prednisolone acetate or dexamethasone) may be used short-term to reduce severe inflammation, but only when corneal ulceration has been ruled out
- Non-steroidal anti-inflammatory drops may be used as alternatives
- Acetylcysteine drops may be prescribed to break down the thick, tenacious mucoid discharge characteristic of KCS
Surgical Options
Surgery is reserved for cases that fail to respond adequately to medical management:
- Parotid duct transposition (PDT) — The duct of the parotid salivary gland is surgically rerouted from the mouth to the eye, allowing saliva to substitute for tears. Saliva is a reasonable substitute because its composition is similar to tears. Potential complications include mineral deposits on the cornea (from salivary minerals) and excessive wetness of the face. This procedure requires a veterinary ophthalmologist or experienced surgeon. Cost: ~$1,500–$3,500 per eye.
- Superficial keratectomy — Surgical removal of corneal scar tissue or pigment to restore vision, performed when medical treatment has stabilized tear production but vision remains impaired. Cost: ~$1,000–$2,500 per eye.
- Third-eyelid flap or conjunctival graft — Used to protect and promote healing of corneal ulcers that develop secondary to KCS.
Alternative/Supportive Therapies
- Omega-3 fatty acid supplementation — Fish oil supplements may support tear film quality by improving the lipid layer, reducing tear evaporation. Dosing should be guided by your veterinarian.
- Warm compresses — Gently applied to the closed eyelids for 5–10 minutes can help loosen discharge and stimulate meibomian gland secretion.
- Environmental modifications — Reducing exposure to wind, air conditioning, smoke, and dry air can minimize tear evaporation.
- Humidifiers — Maintaining indoor humidity levels of 40–60% can benefit dogs with KCS.
At-Home Care
- Consistent medication administration — KCS treatment only works if applied reliably. Missing doses allows inflammation to rebound and damage to progress.
- Gentle daily eye cleaning — Use warm, damp gauze or a soft cloth to clean discharge from around the eyes before applying medications. Always wipe away from the eye.
- Monitor for ulcers — Watch for sudden squinting, increased pain, cloudiness, or changes in discharge. These warrant prompt veterinary attention.
- Protect from eye trauma — Use an Elizabethan collar (cone) if your dog rubs or paws at the eyes excessively.
- Regular veterinary follow-up — Schirmer tear tests should be rechecked every 3–6 months to monitor response to treatment and adjust therapy as needed.
Prognosis & Life Expectancy
KCS itself is not a life-threatening condition, and with appropriate, consistent treatment, most dogs maintain good quality of life and functional vision for many years. The prognosis depends on several factors:
- Severity at diagnosis — Dogs diagnosed early, before significant corneal scarring or pigmentation, have the best visual outcomes.
- Response to treatment — The majority of dogs (70–80%) respond well to cyclosporine or tacrolimus, with measurable increases in tear production within 4–8 weeks. Some dogs achieve near-normal tear values.
- Owner compliance — Because treatment is lifelong and requires daily medication, owner commitment is one of the strongest predictors of long-term outcome.
- Underlying cause — Drug-induced KCS may be partially or fully reversible if the offending medication is discontinued early. Neurogenic KCS sometimes improves if the underlying nerve damage resolves. Immune-mediated KCS is generally permanent but manageable.
With treatment, KCS does not typically reduce a dog's lifespan. The main impact is on comfort and visual quality rather than longevity.
Prevention
True prevention of immune-mediated KCS is not currently possible because the underlying autoimmune trigger remains incompletely understood. However, several measures can reduce risk and improve early detection:
- Breed screening — Owners of predisposed breeds should request baseline Schirmer tear tests during routine wellness examinations, particularly from age 3 onward. Early detection allows treatment to begin before irreversible corneal changes develop.
- Preserve the third-eyelid gland — If your dog develops cherry eye, insist on surgical repositioning (tacking) rather than removal of the gland. Removal significantly increases the risk of KCS later in life.
- Medication awareness — If your dog is prescribed sulfonamide antibiotics or other drugs known to affect tear production, discuss monitoring Schirmer values with your veterinarian.
- Responsible breeding — Breeders of high-risk breeds should consider screening breeding stock and avoiding breeding dogs with diagnosed KCS.
- Prompt treatment of eye problems — Early intervention for any eye condition — infections, allergies, cherry eye — helps preserve tear gland health.
- Regular veterinary checkups — Annual or semi-annual wellness exams that include basic eye assessments can catch early signs of declining tear production.
Cost of Treatment
Understanding the financial commitment of KCS management helps owners plan for long-term care:
| Component | Estimated Cost | |---|---| | Initial veterinary exam with Schirmer tear test | $75–$200 | | Fluorescein stain and basic eye workup | $25–$75 | | Veterinary ophthalmologist consultation | $150–$300 | | Cyclosporine ophthalmic (monthly) | $30–$70 | | Tacrolimus ophthalmic (monthly, compounded) | $40–$90 | | Artificial tear supplements (monthly) | $10–$25 | | Follow-up exams and Schirmer re-checks (per visit) | $50–$150 | | Parotid duct transposition surgery (per eye) | $1,500–$3,500 | | Corneal surgery (keratectomy, per eye) | $1,000–$2,500 | | Annual ongoing treatment cost (medical management) | $500–$1,500 |
Pet insurance may cover a portion of diagnostic and treatment costs if KCS is not considered a pre-existing condition at the time of enrollment. Check your policy for coverage of chronic conditions and specialty referrals.